Kathryn Koprivnikar

1.1k total citations
9 papers, 541 citations indexed

About

Kathryn Koprivnikar is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Kathryn Koprivnikar has authored 9 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Kathryn Koprivnikar's work include CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and Virus-based gene therapy research (2 papers). Kathryn Koprivnikar is often cited by papers focused on CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and Virus-based gene therapy research (2 papers). Kathryn Koprivnikar collaborates with scholars based in United States and Finland. Kathryn Koprivnikar's co-authors include Thomas C. Harding, Karin Jooss, Guang Huan Tu, Alshad S. Lalani, Melinda VanRoey, Bo Luan, Andrew D. Simmons, Rodney A. Prell, Betty Li and Kari Alitalo and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Molecular Therapy.

In The Last Decade

Kathryn Koprivnikar

9 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathryn Koprivnikar United States	7	333	298	158	119	65	9	541
Cody T. Mowery United States	7	308 0.9×	257 0.9×	262 1.7×	98 0.8×	49 0.8×	8	651
Ileana Bortolomai Italy	17	246 0.7×	283 0.9×	122 0.8×	47 0.4×	37 0.6×	20	586
Cathy M. Price United Kingdom	10	224 0.7×	437 1.5×	85 0.5×	84 0.7×	29 0.4×	14	827
Benjamin Mizukawa United States	14	168 0.5×	394 1.3×	161 1.0×	43 0.4×	25 0.4×	37	737
Taihe Lu United States	13	332 1.0×	439 1.5×	103 0.7×	264 2.2×	44 0.7×	15	686
Paula A. Clark United Kingdom	13	260 0.8×	294 1.0×	315 2.0×	32 0.3×	150 2.3×	18	667
Qian‐Lin Hao United States	13	144 0.4×	312 1.0×	316 2.0×	66 0.6×	185 2.8×	17	831
Yanhua Yuan China	12	231 0.7×	276 0.9×	262 1.7×	28 0.2×	43 0.7×	30	508
Dov Zippel Israel	9	474 1.4×	103 0.3×	368 2.3×	160 1.3×	73 1.1×	13	628
Christopher M. Ridler United Kingdom	7	231 0.7×	268 0.9×	171 1.1×	62 0.5×	15 0.2×	10	641

Countries citing papers authored by Kathryn Koprivnikar

Since Specialization

Citations

This map shows the geographic impact of Kathryn Koprivnikar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Koprivnikar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Koprivnikar more than expected).

Fields of papers citing papers by Kathryn Koprivnikar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Koprivnikar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Koprivnikar. The network helps show where Kathryn Koprivnikar may publish in the future.

Co-authorship network of co-authors of Kathryn Koprivnikar

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Koprivnikar. A scholar is included among the top collaborators of Kathryn Koprivnikar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Koprivnikar. Kathryn Koprivnikar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Tu, Guang Huan, et al.. (2010). Antibody responses to galectin-8, TARP and TRAP1 in prostate cancer patients treated with a GM-CSF-secreting cellular immunotherapy. Cancer Immunology Immunotherapy. 59(9). 1313–1323. 25 indexed citations

Harding, Thomas, et al.. (2007). Identification of antibody responses induced in patients with metastatic hormone-refractory prostate cancer (HRPC) treated with a GM-CSF-transduced allogeneic prostate cancer immunotherapy. Cancer Research. 67. 4139–4139. 1 indexed citations

Harding, Thomas C., Alshad S. Lalani, Bo Luan, et al.. (2006). AAV Serotype 8-Mediated Gene Delivery of a Soluble VEGF Receptor to the CNS for the Treatment of Glioblastoma. Molecular Therapy. 13(5). 956–966. 33 indexed citations

Li, Betty, Alshad S. Lalani, Thomas C. Harding, et al.. (2006). Vascular Endothelial Growth Factor Blockade Reduces Intratumoral Regulatory T Cells and Enhances the Efficacy of a GM-CSF–Secreting Cancer Immunotherapy. Clinical Cancer Research. 12(22). 6808–6816. 192 indexed citations

Li, Betty, Alshad S. Lalani, Thomas Harding, et al.. (2005). Blockade of Vascular Endothelial Growth Factor (VEGF) Enhances the Therapeutic Efficacy of GM-CSF Secreting Tumor Cell Vaccines. Journal of Immunotherapy. 28(6). 615–616. 1 indexed citations

Lin, Jianmin, Alshad S. Lalani, Thomas C. Harding, et al.. (2005). Inhibition of Lymphogenous Metastasis Using Adeno-Associated Virus-Mediated Gene Transfer of a Soluble VEGFR-3 Decoy Receptor. Cancer Research. 65(15). 6901–6909. 202 indexed citations

Farson, Deborah, Thomas C. Harding, Jun Liu, et al.. (2004). Development and characterization of a cell line for large‐scale, serum‐free production of recombinant adeno‐associated viral vectors. The Journal of Gene Medicine. 6(12). 1369–1381. 53 indexed citations

DiMaio, Miriam S., Richard A. Barth, Kathryn Koprivnikar, et al.. (1993). First‐trimester prenatal diagnosis of osteogenesis imperfecta type II by DNA analysis and sonography. Prenatal Diagnosis. 13(7). 589–596. 22 indexed citations

Wilkin, Douglas J., Kathryn Koprivnikar, & Daniel H. Cohn. (1993). Heteroduplex Analysis Can Increase the Informativeness of PCR-Amplified VNTR Markers: Application Using a Marker Tightly Linked to the COL2A1 Gene. Genomics. 15(2). 372–375. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact